Top story

Building Confidence in African Traditional Medicines

NAIROBI, 31 August 2026 — African traditional medicines remain an integral part of society and healthcare, but unlocking their full potential requires stronger quality assurance, safety monitoring, scientific evidence, accurate dosing, standardised production and …

Read full story

FDA Approves Updated Covid Vaccines With New Restrictions

The New York Times - Drugs & Pharmaceuticals
By Christina Jewett and Jacey Fortin - Wed, 27 Aug 2025
Read more

FDA Removes Risk Evaluation and Mitigation Strategy (REMS) Program for the Antipsychotic Drug Clozapine

Drugs.com - FDA MedWatch Drug Alerts
Wed, 27 Aug 2025
Read more

Unichem Pharmaceuticals (USA) Inc. Issues Voluntary Nationwide Recall of Cyclobenzaprine Hydrochloride Tablets USP 10 mg, Due to Mislabeling

Drugs.com - FDA MedWatch Drug Alerts
Wed, 27 Aug 2025
Read more

Pfizer and BioNTech’s Comirnaty Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19

Drugs.com - New Drug Approvals
Wed, 27 Aug 2025
Read more

Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccines Targeting LP.8.1 Variant of SARS-CoV-2

Drugs.com - New Drug Approvals
Wed, 27 Aug 2025
Read more

Novavax's Nuvaxovid 2025-2026 Formula COVID-19 Vaccine Approved in the U.S.

Drugs.com - New Drug Approvals
Wed, 27 Aug 2025
Read more

Travere Therapeutics Announces U.S. FDA Approves REMS Modification for Filspari (sparsentan) in IgA Nephropathy

Drugs.com - New Drug Approvals
Wed, 27 Aug 2025
Read more

Gadoquatrane New Drug Application Accepted for Review by U.S. FDA

Drugs.com - New Drug Applications
Wed, 27 Aug 2025
Read more

Celcuity to Initiate NDA Submission of Gedatolisib in PIK3CA Wild-Type Cohort in HR+/HER2- Advanced Breast Cancer Under FDA’s Real-Time Oncology Review Program

Drugs.com - Clinical Trial Results
Wed, 27 Aug 2025
Read more